Accumulation of intracellular
beta-catenin, as a result of inactivation of the
adenomatous polyposis coli (APC) gene or by mutation of the
beta-catenin gene (CTNNB1) itself, is involved in a wide range of human
cancers. By means of fluorescent differential display using a murine fibroblast cell line (L-MT), which expresses an activated form of
beta-catenin that accumulates in the cells, we found that expression of murine
monocyte chemotactic protein-3 (mMCP-3) was suppressed by activated
beta-catenin. Inversely, expression of MCP-3 in human
colon cancer cells was induced by depletion of
beta-catenin after adenovirus-mediated transfer of wild-type APC genes into the cells. A reporter-gene assay indicated that the accumulation of
beta-catenin in the nucleus suppressed activity of the MCP-3 promoter through a putative
T-cell factor/lymphocyte enhancer factor (Tcf/LEF)-binding site, ATCAAAG; but when the promoter sequence contained a two-base substitution in the binding site, it failed to suppress reporter-gene (
luciferase) activity. An electrophoretic mobility-shift assay using the putative Tcf/LEF-binding sequence revealed interaction of the candidate sequence with the
beta-catenin complex. Furthermore, induction of MCP-3
cDNA into HT-29
colon cancer cells increased expression of two markers of differentiation:
alkaline phosphatase and
carcinoembryonic antigen. Our results implied that activation of
beta-catenin through the Tcf/LEF signaling pathway may participate in colonic
carcinogenesis by inhibiting MCP-3-induced differentiation of colorectal epithelial cells.